Since we observed higher FGFR3 expression in statin-sensitive MM cell lines and an association between t(4;14) translocation status and statin sensitivity, we next evaluated whether the deregulated expression of FGFR3 in t(4;14)-positive cells was necessary for the greater statin sensitivity observed in these cells. The gene discussed is FGFR3; the disease is Miyoshi myopathy.